- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Taiwanese Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
4
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
4 companies
Sunmax Biotechnology
Market Cap: NT$22.4b
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
4728
NT$414.50
7D
1.0%
1Y
48.0%
Ever Supreme Bio Technology
Market Cap: NT$13.6b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$155.50
7D
-1.3%
1Y
-7.0%
Handa Pharmaceuticals
Market Cap: NT$12.8b
A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.
6620
NT$81.00
7D
-0.2%
1Y
-9.4%
3D Global Biotech
Market Cap: NT$3.6b
Develops medical materials for human body reconstruction in China.
6808
NT$44.40
7D
-10.6%
1Y
23.2%